Global UAV Technologies enters LOI to acquire Nexus Peptide
VANCOUVER - Global UAV Technologies Ltd. (CSE:UAV) (OTC Pink:YRLLF) (FSE:1OZ) announced today it has entered into a non-binding letter of intent dated July 27, 2026 to acquire all outstanding securities of Nexus Peptide Sciences Inc., a private biotechnology company based in Vancouver.
Reported by 1 outlet — Investing.com · Company News. See all sources ↓
VANCOUVER - Global UAV Technologies Ltd. (CSE:UAV) (OTC Pink:YRLLF) (FSE:1OZ) announced today it has entered into a non-binding letter of intent dated July 27, 2026 to acquire all outstanding securities of Nexus Peptide Sciences Inc., a private biotechnology company based in Vancouver. Under the proposed transaction, the company would issue 20,300,000 common shares and 7,000,000 transferable share purchase warrants to Nexus securityholders on a pro-rata basis, according to a press release statement. Each warrant would be exercisable at $0.10 per share for two years following closing.
Read the full report at Investing.com · Company News ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- VANCOUVER - Global UAV Technologies Ltd. (CSE:UAV) (OTC Pink:YRLLF) (FSE:1OZ) announced today it has entered into a non-binding letter of intent dated July 27, 2026 to acquire all outstanding securities of Nexus Peptide Sciences Inc., a private biotechnology company based in Vancouver.
- How widely is it covered?
- 1 outlet, average source rating 5.0/10.
- When was it last updated?
- 8m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Global UAV Technologies enters LOI to acquire Nexus Peptide
Sources1TypeCoverageInvesting.com · Company News